Im Cannabis Corp (IMCC)
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
AMTD IDEAs Receipt of NYSE Letter Regarding ADS Trading Prices Below Compliance Standards
IM Cannabis Raises US$250,000 of Gross Proceeds in Convertible Note Financing
Kiniksa Pharmaceuticals to Present at Canaccord Genuity 46th Annual Growth Conference
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans
PetVivo Sets Fiscal First Quarter 2027 Conference Call for Friday, August 14, 2026 at 5:00 p.m. ET